The number to call is 855-856-2424. It connects to a live person that will discuss non-24 sleep disorder for the blind and the benefits of Tasimelteon. The market in which I live has some popular AM programs. The radio station they chose is the number 1 AM station in the market.
I am back in! With what is size for me. Heard a non-24 commercial on the radio today. This is a real market. Bigger than people think.
Better get back in, the train is moving upwards again...Be prepared for 13-14 soon, with a pop to 18-19. Then a post-coltal let down to 10..
Iba- I agree that the VP's departure was an indicator eluding to the likely-hood of a buyout rather than bringing the drug to market themselves. Personally, I prefer this strategy since it eliminates the risk of a failed execution on vnda's part in realizing the drug's potential. We shall see though, buyout talk seems to fly around a lot, and very few times have I heard allegations of a buyout and seen that actually take place.
Does this guy just talk to himself here as he does on other boards read this #$%$ wipes posts all of them then kick this loser to the curb. I will post to every post loser clark I will worn people what a pos fraud you are.
I've been in VNDA for over two years. Its been an interesting ride to say the least. I try to watch the Sr.Mgt. team at VNDA and access their actions/activities based on my management intuitions. So far, I'm approving of the way in which they have maneuvered thru the FDA challenges. Look at the incentives that they have given themselves and how they can turn those into hard dollars. The recent departure of the V.P. who was chosen to develop the commercialization strategy is a good indicator of what Sr. Mgt. is focused on. Hint: It's not a commercialization strategy that they are playing out.
While we heard all the nonsense that FDA approval is not a lock and further speculation that the company will not profit off of its sleep drug, I think the market reaction of late tells a different story. People were shorting the stock because there was no news and they could get away with manipulating the price. This selling pandemic scared people and caused some to sell as a reaction to this selling we saw a couple weeks ago. Now, with FDA approval coming any week, people aren't playing russian roulette anymore with this stock bc they KNOW it is getting approved, and that this approval will spark a dramatic upswing in the stock in coming months, I've been in this stock for 9 months, and have probably developed a stomach ulcer or two watching perhaps the most volatile investment I have ever been in swing back and forth over that time on multiple occasions. It feels good to see the light at the end of the tunnel. Good days are coming for vanda pharma and this stock is a buy even at this price with 50% upside or more in the next few months.
Sentiment: Strong Buy
This stock has stabilized and slowly climb as the PDUFA date approaches. I would recommend several strategies. Option One - if your long the stock and it keeps rising, sell some Feb out-of-money puts for lower strike prices. When the stock goes over 14-15, start to also sell Feb calls for higher strike prices. Option Two - if your not long the stock, buy some February calls for 10-12 strike. When the stock goes over 14-15, start to also sell Feb calls for higher strike prices. Option Three - take your chances, and get out shortly after the announcement. Then buy puts for the price gain as the stock drops.. After it drops below 11, undo the puts. Time to move on to other grounds
Mine as well. I have question for those that know the story on this stock- target prices on the stock are pretty much agreed on by all analysts to be between $20-22. I anticipate there will be another "shorting" pandemic following official FDA approval based on (1)speculation that vnda will not see projected profits bc of market size, (2)that vnda will drop the ball on commercializing the drug if they opt to bring it to market themselves. This being the case, is anyone planning on holding this thing long term to see how the drug's profitability plays out, or are you bailing once this thing hits $19-20 to avoid what may be another roller coaster ride post FDA approval?
Most of the shorts will be gone from VNDA soon. Fear is 3X as strong as greed, but the FDA approval is coming soon and that will drive greed. I just heard a commercial on AM radio that I think is from VNDA's PR rep. firm. touting sleep disorders for the blind. I have the 800 number and will call it tomorrow.